HealthQuill Asia
Samsung Biologics has announced a $1.24 billion manufacturing deal with an unnamed Asian pharmaceutical company.
Drugs Health Pharma

CDMO Samsung Biologics signs $1.24 billion drug manufacturing deal

Samsung Biologics has announced a $1.24 billion manufacturing deal with an unnamed Asian pharmaceutical company.

Read More
More than 200 people were murdered worldwide last year while trying to protect their lands and the environment from corporations, governments and non-state actors, according to a Global Witness report.
Climate Health Pharma

More than 200 land defenders died globally in 2023, Colombia deadliest

More than 200 people were murdered worldwide last year while trying to protect their lands and the environment from corporations, governments and non-state.

Read More
Kezar Life Sciences Inc., a US-based biotechnology company, has stopped a trial in patients with a type of kidney disease after four people died.
Drugs Health Pharma

Kezar Life Sciences halts mid-stage lupus nephritis trial after four people die

Kezar Life Sciences Inc., a US-based biotechnology company, has stopped a trial in patients with a type of kidney disease after four people.

Read More
Falling global wages, possibly driven by automation and artificial intelligence, will slow the pace of achieving Sustainable Development Goals (SDG) as the 2030 deadline looms, according to an International Labour Organization report.
Drugs Health Medical

SDG targets in danger as paychecks shrink globally, ILO says

Falling global wages, possibly driven by automation and artificial intelligence, will slow the pace of achieving Sustainable Development Goals (SDG) as the 2030.

Read More
A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9 million HIV people not able to receive treatment owing to a shortage of funds and an anti-rights push, a report stated.
Drugs Health Pharma

Fund crunch, anti-rights push, slowing global target to end AIDS, UN says

A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9.

Read More
June was the hottest month since the records began and the thirteenth month in a row to set a monthly temperature record, according to the European Union’s Copernicus Climate Change Service.
Climate Health Medical

Global heat temperatures break record for 13 months in a row

June was the hottest month since the records began and the thirteenth month in a row to set a monthly temperature record, according.

Read More
Urgent steps are also needed to study the dynamics of the circulating viral strains about its vector, hosts and environment for developing effective preventive and control strategies. Research into the genetic structure of the WNV could also help in future vaccine development strategies. 
Drugs Health Opinion Pharma

Opinion: West Nile Virus’ genetic sequence needs in-depth study

Urgent steps are needed to study the dynamics of the circulating viral strains about its vector, hosts and environment for developing effective preventive.

Read More
The UN’s Gavi, the Vaccine Alliance, has restored its efforts to prevent and control rabies globally by increasing the availability of vaccines and eliminating the disease by 2030 after Covid-19 disrupted its rollout.
Drugs Health Pharma

Vaccine Alliance steps up bid to end rabies by 2030 after Covid-19 pause

The UN’s Gavi, the Vaccine Alliance, has restored its efforts to prevent and control rabies globally by increasing the availability of vaccines and.

Read More
The World Health Organization has prequalified a dengue vaccine for children made by Japan’s Takeda Pharmaceutical Company — the third-largest drug firm in Asia.
Drugs Health Pharma

WHO prequalifies Japan-based Takeda’s dengue vaccine for children

HQ Team May 15, 2024: The World Health Organization has prequalified a dengue vaccine for children made by Japan’s Takeda Pharmaceutical Company —.

Read More
The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.
Drugs Health Pharma

JN.1 sub-variant Covid-19 cases rise to 62% in the US, says CDC 

HQ Team January 8, 2023: The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared.

Read More